Patents by Inventor Gary Eldridge

Gary Eldridge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170232168
    Abstract: A blood pump includes a hub having an axis of rotation and a generally cylindrical shape. The hub has an upstream end region, a central region, and a downstream end region, and the hub includes a magnetic material. Blades that are disposed on the downstream end region of the hub extend downstream of the hub.
    Type: Application
    Filed: November 22, 2016
    Publication date: August 17, 2017
    Inventors: Steven H. Reichenbach, Stephen G. Briana, William V. Hodges, Eric Lee, Yi-Ren Woo, Onur Dur, David Gary Eldridge, Pieter W.C.J le Blanc
  • Patent number: 9562031
    Abstract: The present invention generally relates to phenethyldihydrobenzodioxolone compounds and compositions useful for reducing or inhibiting tumor growth. It also relates to methods of use and the preparation of phenethyldihydrobenzodioxolone compounds.
    Type: Grant
    Filed: September 12, 2015
    Date of Patent: February 7, 2017
    Assignee: Sequoia Sciences, Inc.
    Inventors: Russell B Williams, Gary Eldridge, Courtney M. Starks, Peter Robert Guzzo, Zhongping Huang
  • Publication number: 20170028060
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Application
    Filed: October 17, 2016
    Publication date: February 2, 2017
    Inventors: Gary Eldridge, Steven M Martin
  • Patent number: 9533082
    Abstract: A blood pump includes a hub having an axis of rotation and a generally cylindrical shape. The hub has an upstream end region, a central region, and a downstream end region, and the hub includes a magnetic material. Blades that are disposed on the downstream end region of the hub extend downstream of the hub.
    Type: Grant
    Filed: September 17, 2014
    Date of Patent: January 3, 2017
    Assignee: THORATEC CORPORATION
    Inventors: Steven H. Reichenbach, Stephen G. Briana, William V. Hodges, Eric Lee, Yi-Ren Woo, Onur Dur, David Gary Eldridge, Pieter W. C. J. le Blanc
  • Patent number: 9504743
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: November 29, 2016
    Assignee: Sequoia Sciences, Inc
    Inventors: Gary Eldridge, Steven M Martin
  • Patent number: 9492522
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Grant
    Filed: September 1, 2015
    Date of Patent: November 15, 2016
    Assignee: Sequoia Sciences, Inc.
    Inventors: Gary Eldridge, Steven M Martin
  • Patent number: 9415097
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: August 16, 2016
    Assignee: Sequoia Sciences, Inc.
    Inventors: Gary Eldridge, Steven M. Martin
  • Patent number: 9415101
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: August 16, 2016
    Assignee: Sequoia Sciences, Inc.
    Inventors: Gary Eldridge, Steven M Martin
  • Publication number: 20160220666
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Application
    Filed: April 15, 2016
    Publication date: August 4, 2016
    Inventors: Gary Eldridge, Steven M Martin
  • Publication number: 20160206795
    Abstract: A blood pump includes a rotor having a flared portion downstream proximate a downstream bearing that supports the rotor. The flared portion of the rotor includes a width greater than a width of an upstream portion of the rotor. A blood pump also includes a housing having an internal wall with a flared portion downstream of a motor stator and proximate a transverse outlet.
    Type: Application
    Filed: December 29, 2015
    Publication date: July 21, 2016
    Inventors: Steven H. Reichenbach, Pieter W.C.J. le Blanc, Yi-Ren Woo, David Gary Eldridge, Stephen G. Briana, William V. Hodges, Eric Lee
  • Publication number: 20160193330
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Application
    Filed: February 12, 2016
    Publication date: July 7, 2016
    Inventors: Gary Eldridge, Steven M Martin
  • Publication number: 20160166670
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Application
    Filed: September 1, 2015
    Publication date: June 16, 2016
    Inventors: Gary Eldridge, Steven M. Martin
  • Patent number: 9265870
    Abstract: A blood pump includes a rotor having a flared portion downstream proximate a downstream bearing that supports the rotor. The flared portion of the rotor includes a width greater than a width of an upstream portion of the rotor. A blood pump also includes a housing having an internal wall with a flared portion downstream of a motor stator and proximate a transverse outlet.
    Type: Grant
    Filed: October 13, 2011
    Date of Patent: February 23, 2016
    Assignee: THORATEC CORPORATION
    Inventors: Steven H. Reichenbach, Pieter W. C. J. le Blanc, Yi-Ren Woo, David Gary Eldridge, Stephen G. Briana, William V. Hodges, Eric Lee
  • Publication number: 20150335722
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Application
    Filed: July 15, 2015
    Publication date: November 26, 2015
    Inventors: Gary Eldridge, Steven M. Martin
  • Patent number: 9149522
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Grant
    Filed: March 20, 2015
    Date of Patent: October 6, 2015
    Assignee: Sequoia Sciences, Inc.
    Inventors: Gary Eldridge, Steven M Martin
  • Patent number: 9149521
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Grant
    Filed: March 17, 2015
    Date of Patent: October 6, 2015
    Assignee: Sequoia Sciences, Inc.
    Inventors: Gary Eldridge, Steven M Martin
  • Publication number: 20150216968
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Application
    Filed: March 17, 2015
    Publication date: August 6, 2015
    Inventors: Gary Eldridge, Steven M. Martin
  • Publication number: 20150216969
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Application
    Filed: March 20, 2015
    Publication date: August 6, 2015
    Inventors: Gary Eldridge, Steven M. Martin
  • Patent number: 9017698
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Grant
    Filed: September 23, 2014
    Date of Patent: April 28, 2015
    Assignee: Sequoia Sciences, Inc.
    Inventors: Gary Eldridge, Steven M Martin
  • Publication number: 20150086592
    Abstract: This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
    Type: Application
    Filed: September 23, 2014
    Publication date: March 26, 2015
    Inventors: Gary Eldridge, Steven M Martin